A Study of BL-B01D1 Combination Therapy in Patients With Metastatic Castration-resistant Prostate Cancer
Conditions
- Castration-resistant Prostate Cancer
Interventions
- DRUG: BL-B01D1
- DRUG: Abiraterone
- DRUG: Olaparib
Sponsor
Sichuan Baili Pharmaceutical Co., Ltd.
Collaborators